MIRA INFORM REPORT

 

 

Report Date :

07.11.2007

 

IDENTIFICATION DETAILS

 

Name :

PASCHIM CHEMICALS PRIVATE LIMITED

 

 

Registered Office :

142 AB, Kandivali Industrial Estate, Kandivali (W), Mumbai – 400067, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

03.11.1988

 

 

Com. Reg. No.:

11-49483

 

 

CIN No.:

[Company Identification No.]

U24110MH1988PTC049483

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMP16196F

 

 

PAN No.:

[Permanent Account No.]

AAACP2270J

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Subject is engaged in Manufacturing and Sale Drugs Intermediates, Allopathic pharmaceuticals preparations, conversion charges of chemicals

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

 

Maximum Credit Limit :

USD 188000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is a part of IPCA Group, listed Pharmaceuticals company having fine track records. Directors are reported as experienced, respectable and resourceful businessmen. Their trade relations are fair. General financials position is satisfactory. Payments are usually correct and as per commitments. The company can be considered good for normal business dealings. 

 

 

LOCATIONS

 

Registered Office :

142 AB, Kandivali Industrial Estate, Kandivali (W), Mumbai – 400067, Maharashtra, India.

Tel. No. :

91-22-28688566/ 28682270/ 71/ 66474747

Fax No. :

91-22-28686954

Email :

mary@ipca.co.in

 

 

DIRECTORS

 

Name :

Mr. Kishin C Lala

Designation :

Chairman

Address :

7 Rock House, Hill Road, Worli, Mumbai – 400018, Maharashtra

Date of Birth :

05/06/1938

Date of Appointment :

26/03/1991

 

 

Name :

Mr. Jeevanlal Basantilal Nagori

Designation :

Managing Director

Address :

1004-D Wing, Panchsheel Heights, Mahavir Nagar, Dahanukarwadi, Mumbai – 400 067, Maharashtra, India 

Date of Birth :

10/08/1960

Date of Appointment :`

19/03/1999

 

 

Name :

Mr. Vivek Kumar Shrivastava

Designation :

Director

Address :

Flat No. 803, Tower No. 2, Challenger Tower, Thakur Village, Kandivli (Easst), Mumbai – 400 101, Maharashtra, India

Date of Birth :

16/05/1965

Date of Appointment :

04/03/2002

 

 

Name :

Mr. Prashant Premchand Godha

Designation :

Director

Address :

H.No. 20, Golden Beach Society, Ruia Park, Juhu, Mumbai – 400049, Maharashtra.

Date of Birth :

16//11//1974

Date of Appointment :

4/03/2002

 

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

No. of Shares

Mexin Medicements Private Limited

4500

IPCA Laboratories Limited

6690

Kaygee Inv. Private Limited

5000

Harleystreet Pharmaceuticals Limited

4000

Makers Lab Limited

4000

Chandurkar Inv. Private Limited

9000

Exon Laboratories Private Limited

4500

Win Laboratories Private Limited

4310

Ellora Organics Industries Private Limited

4000

 

Names of Shareholders

 

Percentage of Holding

Bodies Corporate

 

67.47

Directors or Relatives of Directors

 

0.64

Other Top Fifty (50) Shareholder

 

31.89

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Subject is engaged in manufacturing and sale of Drugs Intermediates, Allopathic pharmaceuticals preparations, conversion charges of chemicals

 

 

Products :

Drugs Intermediates

 

Product Description

Item Code No. (ITC No.)

BCFI

2942-00

 

 

PRODUCTION STATUS

 

Particulars

Unit

Basis

Installed Capacity

Actual Production

 

 

 

31.03.05

31.03.04

04-05

03-04

 

 

 

 

 

 

 

Drug Intermediates

Tones

Triple Shift

500.00

500.00

11.158

2.079

 

 

GENERAL INFORMATION

 

No. of Employees :

150

 

 

Bankers :

Axis Bank Limited,

Royal Accord IV, Lokhandwala Complex, Andheri (West), Mumbai – 400 053, Maharashtra, India

 

 

 

 

Facilities :

Secured Loan

(Rs. in millions)

 

31.03.2005

From Axis Bank Limited

20.000

Rabo India Finance Private Limited

50.000

Total

70.000

 

The company enjoy secured loan facility of Rs. 35.000 million from Rabo India Finance Private Limited on FY 2004

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

G R Mantri and Associates

Chartered Accountants

Address:

F – 106, Son Marg, Opp. Bajaj Hall, S V Road, Malad (West), Mumbai – 400 064, Maharashtra, India 

Tel. No.:

91-22-22663342

Fax No.:

91-22-22660267

E-Mail :

jainbl@hotmail.com

 

 

 

Group Companies :

  • IPCA Pharmaceuticals and Chemicals Private Limited
  • IPCA Surgical and Specialities Private Limited
  • Win Laboratories Limited
  • Ellora Organic Industries Private Limited
  • Innotech Pharma Limited
  • IPCA Laboratories Limited  

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4,00,000

Equity Shares

Rs.100/-

Rs.40.000 millions

 

As on 31.03.2006

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

85,690

Equity Shares

Rs.100/-

Rs.8.569 million

 

As on 31.03.2007

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

140, 815

Equity Shares

Rs.100/-

Rs.14.081 million

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

14.081

8.569

5.000

2] Reserves & Surplus

33.117

24.750

6.544

NETWORTH

47.198

33.319

11.544

LOAN FUNDS

 

 

 

1] Secured Loans

90.623

100.000

70.000

TOTAL BORROWING

90.623

100.000

70.000

DEFERRED TAX LIABILITIES

4.542

0.000

3.256

Share Capital Suspense Account 

0.000

1.112

0.000

 

 

 

 

TOTAL

142.363

134.431

84.800

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

66.375

53.290

30.736

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

95.982

95.992

86.645

DEFERREX TAX ASSETS

0..000

0.200

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 
Inventories
5.647
5.457

6.448

 
Sundry Debtors
0.892
3.080

0.312

 
Cash & Bank Balances
1.702
2.247

2.028

 
Loans & Advances
6.921
31.023

3.020

Total Current Assets
15.162

41.807

11.808
Less : CURRENT LIABILITIES & PROVISIONS
 

 

 

 
Current Liabilities
34.988
56.695

44.244

 
Provisions
0.168
0.162

0.145

Total Current Liabilities
35.156

56.857

44.389
Net Current Assets
[19.994]
(15.050)
(32.581)
 

 

 

 

TOTAL

142.363

134.432

84.800

 


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2007

31.03.2006

Sales Turnover [including other income]

56.145

29.482

 

 

 

Profit/(Loss) Before Tax

[1.996]

[16.651]

Provision for Taxation

-

-

Profit/(Loss) After Tax

[1.996]

[16.651]

 

 

 

Expenditure:

 

 

Interest

8.217

4.706

Depreciation

4.223

4.653

Other Expenditure

45.701

36.774

Total Expenditure

58.141

46.133

 

 
KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

PAT / Total Income
(%)

3.55

56.47

9.21
 
 

 

 

 
Net Profit Margin

(PBT/Sales)

(%)

3.55

56.47

13.68
 

 

 

 

 
Return on Total Assets

(PBT/Total Assets}

(%)

2.44

17.50

5.48
 

 

 

 

 
Return on Investment (ROI)

(PBT/Networth)

 

0.04

0.49

0.60
 

 

 

 

 
Debt Equity Ratio

(Total Liability/Networth)

 

5.74

11.19

11.04
 

 

 

 

 
Current Ratio

(Current Asset/Current Liability)

 

0.73

0.26

0.56

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8 Particular for creation or modification of charges 

 

Name of the company

PASCHIM CHEMICALS PRIVATE LIMITED

Presented By

Mr. Prashant Godha, Director

1) Date and description of instrument creating the 

    change

Deed of hypothecation dated 26.03.2002 executed by Paschim Chemicals Private Limited (therin and hereinafter referred to as “the Company”) in favour of Axis Bank Limited. (therein and hereinafter referred to as Axis Bank Limited). A copy of which is enclosed.

2) Amount secured by the charge/amount owing on 

    the securities of charge

Rs. 100.000 millions term loan  (hereinafter referred to as “the facility”)

3) Short particular of the property charged. If the

    property acquired is subject to charge, date of   

    the acquired of the property should be given

All the goods, stocks, raw materials, plant and Machinery, fixtures, implements fittings and other installations, furniture and computers and all other articles and things both present and future whether lying loose or in cases, at site or in transit or which may at any time hereinafter during the continuous of this security be installed or lying loose or in cases of being in or upon or about the borrower factory premises, warehouses, and godowns at G-6, MIDC, Waluj, Aurangabad, Maharashtra, India or wherever else the same may be or be held  any party anywhere to the order and disposition of the borrower or in the course of transit to the borrower (including those goods, machinery, implements, etc, purchased out of the term Loan sanctioned by the Bank covered under the agreement dated 26.03.2002 ) and

 

All the borrower present and future book debts, outstanding monies, receivables, claims, bills, contracts, securities, investments, rights and assets (hereinafter referred to as the “Book Debts”) as security for the due repayment to the bank at any time on demand the total balance outstanding in the various accounts and in installements as agreed in respect of term loan account aling with the interest at the rate hereinafter provide and all costs (including all costs between attorney and client, commission charges and expenses incurred by the bank for the preservation, protection, defense and perfection of the security or for attemped or actual realization thereof and also as security for advances made or which may be made to the borrower or any one or more of them whether alone or jointly or any account current or otherwise and for any liability on bills discounted or held by the bank at the borrower request or bearing the borrower name and also for any other liability on the borrower part to the bank incurred or which may be incurred at the borrower request on any account whatsoever and whether as principal debtor, surety or guarantor together with interest and all customary charges thereon.  

4) Gist of the terms and conditions and extent and

    operation of the charge.

In consideration of Axis Bank Limited,  having agreed to lend and advance to the company the facility, agreement and declaration by the company, inter alia, as follows:

a. Convenant by the company to repay the facility and pay interest and all other monies in the manner set our in the facility agreement dated 26.03.2002 (hereinafter referred to as “the said facility agreement”) between the company and Axis Bank Limited and to comply with the terms and conditions of the said facility agreement.

 

b. The said goods were thereby hypothecated to the Axis Bank Limited, as and by way of first charge as security for and be charged with the repayment of the facility for and be charged with the repayment of the facility with all interest, liquidated damages, commitment charge, premia on prepayment or on redemption, costs, charges, and expenses and all other monies payable by the Company to Axis Bank Limited in respect thereof provided that the charge of Axis Bank Limited on the said goods will be subject to the charge or charges created and or to be created by the company.

In favour of its bankers on its stocks of raw materials, semi finished and finished goods, consumable store and book debts and such other movable as may be agreed to by Axis Bank Limited for securing the borrowing for working capital requirement in the ordinary course of business.

 

c. The company to keep the said goods in marketable and good conditions and also insured as provided therin.

 

d. Power of entry, power to take charge and or possession of seize, recover, receive, appoint receivers of land remove and or sale by public auction or private contract, dispatch, for realization or otherwise dispose off or deal with all or any party of the said goods, etc. as provided therein.   

5) Name and Address and description of the

    person entitled to the charge.

Axis Bank Limited,

Royal Accord IV, Lokhandwala Complex, Andheri (West), Mumbai – 400 053, Maharashtra, India

6) Date  and brief description of instrument

    modifying the charge

Supplemental deed of hypothecation dated 26.09.2003

7) Particulars of modifications specifying the terms

    and conditions or the extent of operations of the  

    charge in which modification is made and the

    details of the modification.

The present modification related to secure the additional term loan of Rs. 35.000 millions granted by them. However, at any point of time the total limit of both the existing outstanding loan amount and the additional term loan shall not exceed the maximum aggregate limit of Rs 100.000 millions

 

The other terms and conditions of the deed of hypothecation dated 26.03.2002 shall remain unchanged.   

 

 

Important Fixed Assets of the company include:

 

1.       Leasehold Land

2.       Factory Building

3.       Plant and Machinery

4.       Effluent Treatment Plant

5.       Furniture and Fixtures

6.       Vehicles

 

 

Operations:

 

The sales and other income from operations of the company for the year under review was Rs.51.026 million compared to Rs.41.639 million for the previous year.

 

Profit after taxation for the year under review amounted to Rs.4.702 million as compared to Rs.0.273 million in the previous year.

 

Dividend:

 

In view of the meager amount of profits, your Directors do not recommend any dividend for the year under review.

 

Auditors:

 

Jain and Kothari, Chartered Accountants, retire as auditors and being eligible offer themselves for re-appointment.

 

 

Employees:

 

The company had no employees covered under Section 217 (2A) of the Companies Act, 1956.

 

Compliance Certificate:

 

A compliance certificate under Section 383A of the Companies Act, 1956, received from the Secretary in whole time practice is attached herewith.      

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.39.29

UK Pound

1

Rs.81.91

Euro

1

Rs.56.96

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions